FIGURE 2.
Comparison of prevalence estimates of select comorbidities and complications limited to an average of 8 y prior to enrollment in PK deficiency NHS or index date in MarketScan. *P < .001 for PK deficiency NHS population vs matched general population. NHS, Natural History Study; PK, pyruvate kinase